z-logo
open-access-imgOpen Access
Monitoring plasmatic concentrations of efavirenz for prediction of clinical outcomes in people living with HIV
Author(s) -
Thaís Lorenna Souza Sales,
Nathália Soares Simões,
Gustavo Machado Rocha,
Keyller Bastos Borges,
Cristiane Aparecida Menezes de Pádua,
Eduardo Sérgio da Silva,
Cristina Sanches
Publication year - 2022
Publication title -
revista de ciências farmacêutica básica e aplicadas - rcfba
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.101
H-Index - 16
eISSN - 2179-443X
pISSN - 1808-4532
DOI - 10.4322/2179-443x.0771
Subject(s) - efavirenz , adverse effect , medicine , receiver operating characteristic , human immunodeficiency virus (hiv) , plasma concentration , pharmacokinetics , area under the curve , antiretroviral therapy , therapeutic drug monitoring , pharmacology , viral load , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom